Recruiting
Basic and Clinical Research of Pregnancy-Induced Hypertension
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
ClinicalTrials.gov IDNCT07464379
PhaseNot Applicable
Enrollment100
SponsorSecond Affiliated Hospital of Wenzhou Medical University
Age20 Years – 50 Years
SexFEMALE
Conditions studied
Pregnancy-induced Hypertension
About this study
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
Interventions
- Other: no Intervention — observation
Primary outcomes
- PIH (Early pregnancy：Weeks 1 to 12 (the first to third months of pregnancy) ；mid-pregnancy：Weeks 13 to 27 (the 4th to 6th month of pregnancy) ；post-delivery period：Weeks 28 to 40 (the 7th to 9th months of pregnancy)；the day of delivery。)
Eligibility information
Inclusion Criteria:
\- Healthy pregnant women, patients with miscarriage, etc.
Exclusion Criteria:
* Heart disease, infections, etc. in pregnant women Uncooperative patients
Study locations
- The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-09.